Novartis Investigative Site
Lengerich 49525
0 studies enrolling now · 1 studies all time
What they study most
Relapsing-remitting Multiple Sclerosis
Studies at this site
Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis
— Completed